术前血浆细胞外囊泡蛋白与颈动脉内膜切除术后长期重大心血管事件高风险相关
在864例颈动脉内膜切除术患者中,术前血浆细胞外囊泡(EV)亚组分中CD14、胱抑素C、serpin F2和serpin C1水平与术后3年重大心血管事件(MACE)风险独立相关,CD14可改善临床模型的预测价值。
要点
- HDL-EV中CD14、胱抑素C、serpin F2、serpin C1升高与MACE风险增加独立相关。
- CD14可改善包含心血管危险因素的临床模型对MACE的预测(NRI=0.16)。
- EV蛋白或可作为CEA术后残余心血管风险的标志物,指导二级预防强化治疗。
核心结论
- 术前血浆EV来源的胱抑素C、serpin C1、CD14和serpin F2水平与CEA术后长期MACE风险增加独立相关,是残余心血管风险的标志物。
- EV来源的CD14水平可改善高危患者识别,这些患者可能受益于二级预防追加治疗以降低未来MACE风险。
研究设计与样本
- 研究纳入Athero-Express生物库中2002至2016年接受CEA的864例患者。
- 从术前血样中分离三种血浆EV亚组分(LDL-EV、HDL-EV和TEX),用ELECTROChemiluminescence免疫分析定量五种蛋白:胱抑素C、serpin C1、serpin G1、serpin F2和CD14。
- 采用多变量Cox比例风险回归分析EV蛋白水平与术后3年MACE(任何卒中、心肌梗死或心血管死亡)风险的关联。
主要发现
- 中位随访3年(IQR 2.2-3.0)期间,137例(16%)患者发生MACE。
- 在HDL-EV亚组分中,CD14每增加1个标准差,MACE风险调整后HR为1.30(95%CI 1.15-1.48)。
- 胱抑素C每增加1个标准差,MACE风险调整后HR为1.22(95%CI 1.06-1.42)。
- serpin F2每增加1个标准差,MACE风险调整后HR为1.36(95%CI 1.16-1.61)。
- serpin C1每增加1个标准差,MACE风险调整后HR为1.29(95%CI 1.10-1.51);serpin G1无显著关联。
关键数值与推荐
- CD14改善临床模型预测价值的净重分类指数为0.16(95%CI 0.08-0.21)。
临床怎么用
- 对于接受CEA的患者,术前可检测HDL-EV中CD14、胱抑素C、serpin F2和serpin C1水平以辅助识别MACE高危患者。
- CD14水平可能有助于筛选适合在标准二级预防基础上追加治疗的高危患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients undergoing carotid endarterectomy (CEA) maintain a substantial residual risk of major cardiovascular events (MACE). Improved risk stratification is warranted to select high risk patients qualifying for secondary add on therapy. Plasma extracellular vesicles (EVs) are involved in atherothrombotic processes and their content has been related to the presence and recurrence of cardiovascular events. The association between pre-operative levels of five cardiovascular disease related proteins in plasma EVs and the post-operative risk of MACE was assessed. METHODS: In 864 patients undergoing CEA from 2002 to 2016 included in the Athero-Express biobank, three plasma EV subfractions (low density lipoprotein [LDL], high density lipoprotein [HDL], and tiny extracellular vesicles [TEX]) were isolated from pre-operative blood samples. Using an electrochemiluminescence immunoassay, five proteins were quantified in each EV subfraction: cystatin C, serpin C1, serpin G1, serpin F2, and CD14. The association between EV protein levels and the three year post-operative risk of MACE (any stroke, myocardial infarction, or cardiovascular death) was evaluated using multivariable Cox proportional hazard regression analyses. RESULTS: During a median follow up of three years (interquartile range 2.2 - 3.0), 137 (16%) patients developed MACE. In the HDL-EV subfraction, increased levels of CD14, cystatin C, serpin F2, and serpin C1 were associated with an increased risk of MACE (adjusted hazard ratios per one standard deviation increase of 1.30, 95% confidence interval [CI] 1.15-1.48; 1.22, 95% CI 1.06-1.42; 1.36, 95% CI 1.16-1.61; and 1.29, 95% CI 1.10-1.51; respectively), independently of cardiovascular risk factors. No significant associations were found for serpin G1. CD14 improved the predictive value of the clinical model encompassing cardiovascular risk factors (net re-classification index = 0.16, 95% CI 0.08-0.21). CONCLUSION: EV derived pre-operative plasma levels of cystatin C, serpin C1, CD14, and serpin F2 were independently associated with an increased long term risk of MACE after CEA and are thus markers for residual cardiovascular risk. EV derived CD14 levels could improve the identification of high risk patients who may benefit from secondary preventive add on therapy in order to reduce future risk of MACE.
引用
- Timmerman N, Waissi F, Dekker M, et al. Pre-Operative Plasma Extracellular Vesicle Proteins are Associated with a High Risk of Long Term Secondary Major Cardiovascular Events in Patients Undergoing Carotid Endarterectomy. Eur J Vasc Endovasc Surg. 2021. PMID: 34511318. doi:10.1016/j.ejvs.2021.06.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。